Skip to main content

September 2020

academics

 

Clinical research courses

Pharma Recruitment at NDTL (7 posts) - Government of India | Salary Rs 60000 pm

Career for M.Pharm, M.Sc as Research Associate at University of Hyderabad

The University of Hyderabad (UoH), one of the major institutions of higher education in India is largely devoted to postgraduate studies and is widely known for its excellence in research and for its distinguished faculty. Founded in 1974 with Prof. Gurbaksh Singh as its first Vice Chancellor, UoH - also known as Hyderabad Central University or HCU- has emerged as a leading centre of teaching and research.

Video : Global Transformation in Health - World Pharmacist day

The world pharmacist day is used to highlight the value of the pharmacy profession to stakeholders and also to celebrate pharmacy globally. It was originally adopted in 2009 at the World Congress of Pharmacy and Pharmaceutical Sciences.

Vaccine Innovator, Bharat Biotech announces today, a licensing agreement with Washington University School of Medicine in St. Louis for a novel chimp- adenovirus, single dose intranasal vaccine for COVID-19. Bharat Biotech owns the rights to distribute the vaccine in all markets except USA, Japan and Europe.

The Council of Scientific & Industrial Research (CSIR), India’s premier research organization, and Mylan Laboratories Limited, the India-based subsidiary of leading global pharmaceutical company Mylan, today announced a partnership to address unmet patient needs amidst the evolving COVID-19 pandemic. Under the partnership, CSIR’s constituent laboratory Indian Institute of Chemical Technology (CSIR-IICT), and Mylan will collaborate to identify potential therapies for COVID-19.

A series of clinical trials will be conducted towards new and innovative solutions to manage COVID-19 pandemic in India as part of this collaboration. The first of the clinical trial to be rolled out is a multiple arm phase 3 study that will be conducted in adult patients with mild to moderate COVID -19 at risk of complications.

Director General of CSIR, Dr. Shehkar C Mande stated, “The current collaboration with Mylan is a significant milestone and during the current COVID-19 pandemic, CSIR has prioritized conducting clinical trials of well proven drugs in partnership with industry towards the development of multiple therapeutic options for COVID-19.” 


Director of CSIR-IICT, Dr Chandrasekhar said, “CSIR is delighted to associate with Mylan as knowledge and scientific partner, and looks forward to working with the company, especially given Mylan’s vast industry experience in clinical trials and commercialization.”  

Mylan Chief Operating Officer, Sanjeev Sethi stated, “Our collaboration with CSIR, India’s premier research organization, is a strategic step forward aimed at identifying effective treatments for patients with COVID-19. In addition to bringing forward new indications, this partnership will also help us identify multiple molecules that can potentially be leveraged in therapies for various other infectious diseases in the future. Mylan is cognizant of its responsibility in fighting this pandemic and continues to leverage its global resources and capabilities including R&D, clinical research, regulatory, manufacturing and supply chain, while engaging with key stakeholders to serve patients in need.”


The application for the clinical trials has been submitted to the Drugs Controller General of India (DCGI) for regulatory approval.

<< Back to Pharma News

Subscribe to PharmaTutor News Alerts by Email

Job Openings for D.Pharm, B.Pharm in DHFWS - Government Jobs | 17 Openings

Job for Junior Research Fellow at Agharkar Research Institute

Job for Research Associate at Hetero Biopharma

Production, Warehouse Jobs at Sun Pharma | B.Pharm, D.Pharm